Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Diagnostic Value of 68Ga-C1 PET/ CT Imaging in Clear Cell Renal Cell Carcinoma

NCT06519760 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT06519760
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06519760 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Diagnostic Value of 68Ga-C1 PET/ CT Imaging in Clear Cell Renal Cell Carcinoma
Lead sponsor
Peking University First Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
July 30, 2024
Completion date
December 31, 2026
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carbonic anhydrase ix, clear cell renal cell carcinoma, pet-ct